Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
Go back to Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 145.55 -3.32 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.87 | 52 Week High | $0.52 | |||
| Open | $153.62 | 52 Week Low | $0.08 | |||
| Day High | $154.69 | P/E | N/A | |||
| Day Low | $141.52 | EPS | $-3.80 | |||
| Volume | 14,966,683 | |||||
